Centre Hospitalier Universitaire Dijon
Clinical trials sponsored by Centre Hospitalier Universitaire Dijon, explained in plain language.
-
Experimental drug targets rare overgrowth disorder in early trial
Disease control TerminatedThis trial tested a drug called taselisib for people with PIK3CA-related overgrowth, a rare condition where parts of the body grow too much due to a genetic mutation. The goal was to see if the drug is safe and can shrink or slow the overgrowth. The study was stopped early, so re…
Phase: PHASE1, PHASE2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 16, 2026 08:06 UTC
-
Diabetes Drug's effect on fatty liver studied, but trial halted
Disease control TerminatedThis study looked at whether liraglutide, a diabetes medication, can reduce fat in the liver and improve blood fat levels in people with type 2 diabetes. It involved 127 participants and used advanced imaging and blood tests. The trial was terminated early, so results are limited…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 16, 2026 08:06 UTC
-
Could a common sedative reverse deadly shock?
Disease control TerminatedThis study tested whether a sedative called dexmedetomidine could help patients with severe septic shock respond better to blood-pressure-raising medications. Septic shock is a life-threatening condition where blood pressure drops dangerously low, and some patients stop respondin…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Heart drug fails to help patients off life support in terminated trial
Disease control TerminatedThis study tested whether the drug levosimendan could help people with severe heart failure safely come off a heart-lung machine (ECLS). The trial planned to include 82 adults who were ready to try weaning off the machine. However, the study was terminated early, so results are l…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Personality and diabetes: does being impatient change your genes?
Knowledge-focused TerminatedThis study looked at whether people with Type 1 or Type 2 diabetes who have different personality types (Type A, proactive and impatient, versus Type B, calm and slow) also have different genetic markers related to inflammation and stress. Researchers collected blood samples and …
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 16, 2026 08:03 UTC
-
Blood cancer drug ibrutinib linked to heart issues – new study investigates
Knowledge-focused TerminatedThis study aimed to understand why some people taking the blood cancer drug ibrutinib develop heart problems like atrial fibrillation (irregular heartbeat) and high blood pressure. Researchers planned to follow 8 patients over time, using special heart tests to find early warning…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 16, 2026 08:02 UTC
-
Dialysis timing study in septic shock halted: no clear winner
Knowledge-focused TerminatedThis study looked at 500 adults in intensive care with septic shock and severe acute kidney injury. It compared starting dialysis early (within 12 hours) versus waiting 48-60 hours to see if timing affected survival at 90 days. The study was terminated early, so no firm conclusio…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Eye scans may predict kidney failure risk after surgery
Knowledge-focused TerminatedThis study looked at whether a simple, non-invasive eye scan could predict how well a person's remaining kidney will work one year after having a kidney removed for cancer. Researchers examined 30 adults before and after surgery, comparing eye blood vessel patterns with kidney fu…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Diabetes drug may alter your food cravings, study finds
Knowledge-focused TerminatedThis study looked at how taste, food cravings, and eating behavior differ in people with type 2 diabetes compared to healthy individuals. It also examined whether the diabetes drug liraglutide changes these factors. The study involved 90 participants split into three groups: diab…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
Blood bubbles may reveal Cancer's next move
Knowledge-focused TerminatedThis study looked at whether tiny particles called exosomes, found in the blood of colorectal cancer patients, can be used as biomarkers to predict survival and disease progression. Researchers analyzed blood samples from 172 participants to see if the number, size, and contents …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
New score may help eye surgeons predict recovery
Knowledge-focused TerminatedThis study aimed to confirm if a score based on age, symptom duration, initial vision, and eye scans can predict good vision recovery one year after combined cataract and epiretinal membrane surgery. The study planned to enroll 164 adults aged 40 and older. The goal was to give s…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC
-
Ventilator impact on immune cells under microscope in ARDS study
Knowledge-focused TerminatedThis study looked at how mechanical ventilation affects the energy centers (mitochondria) of immune cells in the lungs and blood of patients with acute respiratory distress syndrome (ARDS). Researchers aimed to understand if these changes contribute to worse outcomes. The study w…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC
-
Mindfulness for caregivers: a Stress-Reduction experiment that ended early
Knowledge-focused TerminatedThis study aimed to see if a mindfulness-based stress reduction program could lower stress and inflammation in people caring for someone with a severe psychiatric disorder like schizophrenia or bipolar disorder. Researchers planned to compare a group that took mindfulness classes…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 04, 2026 16:19 UTC